SBIR/STTR Research Award
RememberStuff: a dyadic-focused technology to support persons with Alzheimer's disease in the community
Award amount
$316,895Program and phase
STTR · Phase IAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- EPERTURE LLC
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-08-30
- UEI
- VCCMKTZZNKJ3
- Solicitation number
- PA19-270
- Topic code
- NIA
Research abstract
Project Abstract
An estimated 5.7 million Americans have Alzheimer’s disease or a related dementia (ADRD) and one in ten
people age 65 or older show symptoms of Alzheimer’s disease. As ADRD progresses so does the level of
dependency on others. As the disease progresses, higher levels of dependence in people with Alzheimer’s
disease are associated with significantly increased burden and costs of informal care. Today, 41 percent of care
support provided to older adults with ADRD is provided by family members, friends or other unpaid informal
caregivers. Eperture, an Indiana-based woman-owned small business, is developing a technology known as
RememberStuff® (R/S) that is designed to address many of the shortcomings seen in current solutions to serve
ADRD patients and their caregivers on the market. R/S manages and supports common tasks of caregiving and
keeps open the lines of communication between the patient-caregiver dyad. R/S is an in-home kiosk with
customized hardware and software!(touch-screen computer screen with a camera) that enables secure (e.g. off
line) bi-directional communications between caregivers and individuals with Alzheimer’s disease. The overall
goal of R/S technology is to work with the ADRD dyad to: 1) keep the person with ADRD as independent as
possible for as long as possible, and 2) support that person’s caregiving network.!R/S has been designed from
the ground up by a team with caregiving and technology experience to address the limitations and shortfalls of
other caregiving options on the market. Once fully developed, R/S will also provide data and feedback for clinical
and basic science researchers to gain a further understanding of the relationship between dementia patient
needs and the burden of stress experienced by caregivers. In this STTR, Eperture and its research partners at
Indiana University Center for Aging Research and technical partners will continue to develop and enhance the
R/S technology to enhance its acceptance to the affected market. Specifically, the overall goal of Phase I is to
demonstrate feasibility and usability of RememberStuff among the Alzheimer’s disease dyad. To achieve this
goal, Eperture will complete the following Specific Aims: 1) Test the usability and acceptability of R/S among 25
dyads of older adults with ADRD and their primary caregiver; 2) Enhance R/S to include data collection and data
visualization tools for both caregiver and patient; and, 3) Prioritize results of Aim 2 with the full team to identify
both design and function (software and hardware) enhancements for resolution in the next R/S design iteration
in preparation for the outcomes study (Phase II). At the end of Phase I, Eperture and its research partners will
have demonstrated the usability of R/S among its target population. Phase II efforts will focus on updates and
enhancements identified in Phase I and a larger scale study to determine the effectiveness of R/S on measurably
reducing caregiver stress and helping older adults with ADRD maintain independence.Narrative
Alzheimerandapos;s disease and related dementias (ADRD) is a major global health concern with huge implications for
individuals and society. An estimated 5.7 million Americans have ADRD and 1 in 10 people ≥65 years of age
show symptoms. Almost half of all individuals with ADRD are cared for by family members, friends or other
unpaid informal and often untrained caregivers. This STTR will support the development of a tool to manage and
support common tasks of caregiving and keeps open the lines of communication between the patient-caregiver
dyad.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease